IBDEI39T ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,54964,0)
 ;;=D58.9^^256^2775^85
 ;;^UTILITY(U,$J,358.3,54964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54964,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,54964,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,54964,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,54965,0)
 ;;=C81.99^^256^2775^86
 ;;^UTILITY(U,$J,358.3,54965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54965,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,54965,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,54965,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,54966,0)
 ;;=C81.90^^256^2775^87
 ;;^UTILITY(U,$J,358.3,54966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54966,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,54966,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,54966,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,54967,0)
 ;;=D89.2^^256^2775^88
 ;;^UTILITY(U,$J,358.3,54967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54967,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,54967,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,54967,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,54968,0)
 ;;=D05.12^^256^2775^89
 ;;^UTILITY(U,$J,358.3,54968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54968,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,54968,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,54968,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,54969,0)
 ;;=D05.11^^256^2775^90
 ;;^UTILITY(U,$J,358.3,54969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54969,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,54969,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,54969,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,54970,0)
 ;;=D05.10^^256^2775^91
 ;;^UTILITY(U,$J,358.3,54970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54970,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,54970,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,54970,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,54971,0)
 ;;=D50.0^^256^2775^92
 ;;^UTILITY(U,$J,358.3,54971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54971,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,54971,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,54971,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,54972,0)
 ;;=D50.9^^256^2775^93
 ;;^UTILITY(U,$J,358.3,54972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54972,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,54972,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,54972,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,54973,0)
 ;;=C46.9^^256^2775^94
 ;;^UTILITY(U,$J,358.3,54973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54973,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,54973,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,54973,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,54974,0)
 ;;=C22.0^^256^2775^95
 ;;^UTILITY(U,$J,358.3,54974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54974,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,54974,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,54974,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,54975,0)
 ;;=D05.02^^256^2775^96
 ;;^UTILITY(U,$J,358.3,54975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54975,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,54975,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,54975,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,54976,0)
 ;;=D05.01^^256^2775^97
 ;;^UTILITY(U,$J,358.3,54976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54976,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,54976,1,4,0)
 ;;=4^D05.01
